These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 38432865)
1. Value of nuclide scintigraphy in the diagnosis and prognosis of cardiac amyloidosis. Mo Q; Deng Z; Xiao Y; Liu C; Zhao M Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 48(11):1739-1745. PubMed ID: 38432865 [TBL] [Abstract][Full Text] [Related]
2. Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis. Galat A; Rosso J; Guellich A; Van Der Gucht A; Rappeneau S; Bodez D; Guendouz S; Tissot CM; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Itti E; Meignan M; Damy T Amyloid; 2015; 22(4):210-20. PubMed ID: 26465835 [TBL] [Abstract][Full Text] [Related]
3. Role of Nuclear Imaging in Cardiac Amyloidosis Management: Clinical Evidence and Review of Literature. Frantellizzi V; Cosma L; Pani A; Pontico M; Conte M; De Angelis C; De Vincentis G Curr Med Imaging; 2020; 16(8):957-966. PubMed ID: 33081658 [TBL] [Abstract][Full Text] [Related]
5. A challenging road to diagnosing transthyretin cardiac amyloidosis and using technetium-99m pyrophosphate bone scintigraphy in nuclear cardiology - A case report. Kavita A; Abdul Onny MA; Suppiah S; Abdul Aziz AF; Hashim H; Raja Shariff RE; Ng CS Med J Malaysia; 2021 Sep; 76(5):762-767. PubMed ID: 34508392 [TBL] [Abstract][Full Text] [Related]
6. Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate: A Test in Evolution. Poterucha TJ; Elias P; Bokhari S; Einstein AJ; DeLuca A; Kinkhabwala M; Johnson LL; Flaherty KR; Saith SE; Griffin JM; Perotte A; Maurer MS JACC Cardiovasc Imaging; 2021 Jun; 14(6):1221-1231. PubMed ID: 33221204 [TBL] [Abstract][Full Text] [Related]
7. Multimodal Imaging and Biomarkers in Cardiac Amyloidosis. Jung MH; Chang S; Han EJ; Youn JC Diagnostics (Basel); 2022 Mar; 12(3):. PubMed ID: 35328180 [TBL] [Abstract][Full Text] [Related]
8. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis. Hutt DF; Quigley AM; Page J; Hall ML; Burniston M; Gopaul D; Lane T; Whelan CJ; Lachmann HJ; Gillmore JD; Hawkins PN; Wechalekar AD Eur Heart J Cardiovasc Imaging; 2014 Nov; 15(11):1289-98. PubMed ID: 24939945 [TBL] [Abstract][Full Text] [Related]
9. Non-invasive detection and differentiation of cardiac amyloidosis using Takasone K; Katoh N; Takahashi Y; Abe R; Ezawa N; Yoshinaga T; Yanagisawa S; Yazaki M; Oguchi K; Koyama J; Sekijima Y Amyloid; 2020 Dec; 27(4):266-274. PubMed ID: 32722948 [TBL] [Abstract][Full Text] [Related]
10. Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with Saleem M; Sadat B; Van Harn M; Ananthasubramaniam K Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837580 [No Abstract] [Full Text] [Related]
11. Nuclear Imaging for the Diagnosis of Cardiac Amyloidosis in 2021. Li W; Uppal D; Wang YC; Xu X; Kokkinidis DG; Travin MI; Tauras JM Diagnostics (Basel); 2021 May; 11(6):. PubMed ID: 34070853 [TBL] [Abstract][Full Text] [Related]
12. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable. Rubin J; Maurer MS Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086 [TBL] [Abstract][Full Text] [Related]
19. Awareness of Nuclear Medicine Physicians in Romania Regarding the Diagnostic of Cardiac Amyloidosis-A Survey-Based Study. Stan C; Mititelu R; Adam RD; Jurcuţ R Diagnostics (Basel); 2022 Feb; 12(2):. PubMed ID: 35204645 [TBL] [Abstract][Full Text] [Related]